Optimal treatment of steroid sensitive nephrotic syndrome in children

ISRCTN ISRCTN27871415
DOI https://doi.org/10.1186/ISRCTN27871415
Secondary identifying numbers NTR255
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
25/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr N Rijswijk, van
Scientific

Erasmus Medical Centre
Sophia Children's Hospital
Fellow pediatric nephrology
P.O Box 2040
Rotterdam
3000 CA
Netherlands

Phone +31 (0)10 4636588
Email n.vanrijswijk@erasmusmc.nl

Study information

Study designMulticentre randomised double blind placebo controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesSpreading the same cumulative dose of corticosteroids over a longer period of time will lower the relapse rate in steroid sensitive nephrotic syndrome in children
Ethics approval(s)Received from local medical ethics committee
Health condition(s) or problem(s) studiedMinimal Change Nephrotic Syndrome(MCNS), Nephrotic syndrome
InterventionPrednisolone therapy
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Prednisolone
Primary outcome measure1. Number of patients in remission
2. Number of relapses
3. Number of patients with frequently relapsing nephrotic syndrome
Secondary outcome measuresCumulative dose of prednisolon during follow up
Overall study start date01/01/2005
Completion date31/12/2014

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit9 Months
Upper age limit16 Years
SexBoth
Target number of participants340
Key inclusion criteria1. Children from 9 months up to 16 years will be included
2. Only children with idiopathic nephrotic syndrome will be included
Key exclusion criteria1. Children with nephrotic syndrome due to a specific disease
2. Children with more than five relapses
3. Children younger than 9 months or older than 16 years
Date of first enrolment01/01/2005
Date of final enrolment31/12/2014

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Erasmus Medical Centre,
Rotterdam
3000 CA
Netherlands

Sponsor information

Erasmus Medical Centre (Netherlands)
Hospital/treatment centre

Sophia Children's Hospital
Dr. Molewaterplein 60
Rotterdam
3015 GJ
Netherlands

Phone +31 (0)10 4636363
Email info@nierstichting.nl
ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Charity

Dutch Kidney Foundation (Nierstichting Nederland) (Netherlands)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Dutch Kidney Foundation
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan